<DOC>
	<DOCNO>NCT03027362</DOCNO>
	<brief_summary>The goal study : 1 ) investigate efficacy combine ketamine intensive cognitive behavioral therapy ( CBT ) sustain antidepressant effect ketamine ; 2 ) determine ketamine 's delayed effect learn memory , explore relationship ketamine-induced change learn memory duration antidepressant efficacy , without CBT augmentation . Subjects diagnosis MDD treatment-resistant least 2 antidepressant choose pursue clinical ketamine treatment Yale Psychiatric Hospital recruit study .</brief_summary>
	<brief_title>Cognitive Therapy Sustain Antidepressant Effects Intravenous Ketamine Treatment-resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Suffering major depressive episode base Diagnostic Statistical manual ( DSM ) 5 criterion fail one standard antidepressant treatment current episode Hamilton Depression Rating Scale ( 17HAMD ) score 21 prior ketamine treatment . Planned clinical treatment ketamine Yale Psychiatric Hospital ( YPH ) As purpose study determine feasibility efficacy CBT sustain antidepressant effect ketamine , achieve clinical response ( i.e. , 50 % reduction depression symptom , measure MontgomeryAsberg Depressive Rating Scale ( MADRS ) eligible randomization . Patients must treatment resistant least two drug use treat depression . Any Axis I Axis II Disorder , screen clinically predominant depressive episode predominant depressive episode time within 6 month prior screen Active suicidal thought plan Current recent ( &lt; 6 month ago ) substance use disorder Nonaffective psychosis ( schizophrenia schizoaffective disorder ) Inability speak English fluently A clinically significant abnormality screen physical examination might affect safety , study participation , confound interpretation study result Dementia , delirium , neurological mental disease might affect cognition ability meaningfully participate cognitive behavioral therapy ( CBT ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>